- Home
- GSRT vs INZY Comparison
GSRT vs INZY Comparison
Compare GSRT & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSRT
- INZY
- Stock Information
- Founded
- GSRT 2023
- INZY 2015
- Country
- GSRT United States
- INZY United States
- Employees
- GSRT N/A
- INZY N/A
- Industry
- GSRT
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- GSRT
- INZY Health Care
- Exchange
- GSRT Nasdaq
- INZY Nasdaq
- Market Cap
- GSRT 316.5M
- INZY 256.3M
- IPO Year
- GSRT 2024
- INZY 2020
- Fundamental
- Price
- GSRT $10.98
- INZY $4.00
- Analyst Decision
- GSRT
- INZY Buy
- Analyst Count
- GSRT 0
- INZY 9
- Target Price
- GSRT N/A
- INZY $15.22
- AVG Volume (30 Days)
- GSRT 1.3M
- INZY 987.9K
- Earning Date
- GSRT 01-01-0001
- INZY 08-05-2025
- Dividend Yield
- GSRT N/A
- INZY N/A
- EPS Growth
- GSRT N/A
- INZY N/A
- EPS
- GSRT 0.14
- INZY N/A
- Revenue
- GSRT N/A
- INZY N/A
- Revenue This Year
- GSRT N/A
- INZY N/A
- Revenue Next Year
- GSRT N/A
- INZY N/A
- P/E Ratio
- GSRT $75.43
- INZY N/A
- Revenue Growth
- GSRT N/A
- INZY N/A
- 52 Week Low
- GSRT $9.86
- INZY $0.72
- 52 Week High
- GSRT $11.49
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- GSRT N/A
- INZY 83.86
- Support Level
- GSRT N/A
- INZY $3.94
- Resistance Level
- GSRT N/A
- INZY $3.97
- Average True Range (ATR)
- GSRT 0.00
- INZY 0.01
- MACD
- GSRT 0.00
- INZY -0.10
- Stochastic Oscillator
- GSRT 0.00
- INZY 100.00
About GSRT GSR III Acquisition Corp. Ordinary Shares
GSR III Acquisition Corp is a blank check company.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.